Wells Fargo’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $290M | Buy |
1,895,677
+53,634
| +3% | +$8.22M | 0.05% | 287 |
|
|
2025
Q4 | $254M | Buy |
1,842,043
+12,199
| +0.7% | +$1.6M | 0.05% | 327 |
|
|
2025
Q3 | $235M | Sell |
1,829,844
-33,424
| -2% | -$4.08M | 0.04% | 336 |
|
|
2025
Q2 | $225M | Sell |
1,863,268
-32,693
| -2% | -$3.68M | 0.05% | 330 |
|
|
2025
Q1 | $211M | Sell |
1,895,961
-1,610
| -0.1% | -$171K | 0.05% | 318 |
|
|
2024
Q4 | $185M | Sell |
1,897,571
-86,276
| -4% | -$9.2M | 0.04% | 346 |
|
|
2024
Q3 | $228M | Sell |
1,983,847
-104,727
| -5% | -$11.9M | 0.05% | 299 |
|
|
2024
Q2 | $222M | Buy |
2,088,574
+78,448
| +4% | +$7.87M | 0.05% | 291 |
|
|
2024
Q1 | $194M | Buy |
2,010,126
+6,578
| +0.3% | +$674K | 0.05% | 309 |
|
|
2023
Q4 | $202M | Sell |
2,003,548
-5,631
| -0.3% | -$544K | 0.05% | 293 |
|
|
2023
Q3 | $205M | Sell |
2,009,179
-53,871
| -3% | -$5.47M | 0.06% | 270 |
|
|
2023
Q2 | $208M | Sell |
2,063,050
-97,661
| -5% | -$9.77M | 0.06% | 269 |
|
|
2023
Q1 | $199M | Buy |
2,160,711
+12,795
| +0.6% | +$1.12M | 0.06% | 270 |
|
|
2022
Q4 | $195M | Sell |
2,147,916
-169,269
| -7% | -$14.3M | 0.06% | 274 |
|
|
2022
Q3 | $176M | Sell |
2,317,185
-311,335
| -12% | -$25.8M | 0.06% | 280 |
|
|
2022
Q2 | $222M | Sell |
2,628,520
-456,224
| -15% | -$40M | 0.07% | 245 |
|
|
2022
Q1 | $271M | Sell |
3,084,744
-81,300
| -3% | -$7.04M | 0.07% | 238 |
|
|
2021
Q4 | $277M | Sell |
3,166,044
-2,149,285
| -40% | -$178M | 0.07% | 236 |
|
|
2021
Q3 | $435M | Sell |
5,315,329
-80,504
| -1% | -$7.24M | 0.1% | 200 |
|
|
2021
Q2 | $492M | Sell |
5,395,833
-416,666
| -7% | -$37.1M | 0.11% | 185 |
|
|
2021
Q1 | $497M | Sell |
5,812,499
-540,304
| -9% | -$48.5M | 0.11% | 175 |
|
|
2020
Q4 | $600M | Sell |
6,352,803
-219,999
| -3% | -$19.2M | 0.14% | 148 |
|
|
2020
Q3 | $572M | Sell |
6,572,802
-1,836
| -0% | -$159K | 0.16% | 139 |
|
|
2020
Q2 | $574M | Sell |
6,574,638
-66,643
| -1% | -$5.75M | 0.17% | 134 |
|
|
2020
Q1 | $548M | Sell |
6,641,281
-107,723
| -2% | -$9.61M | 0.19% | 118 |
|
|
2019
Q4 | $639M | Buy |
6,749,004
+35,100
| +0.5% | +$3.15M | 0.17% | 128 |
|
|
2019
Q3 | $583M | Buy |
6,713,904
+20,818
| +0.3% | +$1.87M | 0.17% | 131 |
|
|
2019
Q2 | $611M | Sell |
6,693,086
-2,050,141
| -23% | -$174M | 0.17% | 127 |
|
|
2019
Q1 | $753M | Sell |
8,743,227
-52,918
| -0.6% | -$4.25M | 0.22% | 99 |
|
|
2018
Q4 | $676M | Buy |
8,796,145
+248,368
| +3% | +$19.3M | 0.22% | 97 |
|
|
2018
Q3 | $660M | Sell |
8,547,777
-109,850
| -1% | -$8.12M | 0.19% | 116 |
|
|
2018
Q2 | $586M | Sell |
8,657,627
-96,129
| -1% | -$6.63M | 0.17% | 126 |
|
|
2018
Q1 | $634M | Sell |
8,753,756
-34,786
| -0.4% | -$2.65M | 0.19% | 119 |
|
|
2017
Q4 | $661M | Buy |
8,788,542
+1,542
| +0% | +$116K | 0.19% | 115 |
|
|
2017
Q3 | $676M | Buy |
8,787,000
+157,059
| +2% | +$11.9M | 0.21% | 100 |
|
|
2017
Q2 | $645M | Sell |
8,629,941
-1,526,553
| -15% | -$108M | 0.21% | 103 |
|
|
2017
Q1 | $676M | Buy |
10,156,494
+1,102,944
| +12% | +$73.5M | 0.22% | 99 |
|
|
2016
Q4 | $591M | Buy |
9,053,550
+686,641
| +8% | +$44.5M | 0.21% | 110 |
|
|
2016
Q3 | $592M | Buy |
8,366,909
+7,878
| +0.1% | +$574K | 0.22% | 99 |
|
|
2016
Q2 | $618M | Buy |
8,359,031
+133,476
| +2% | +$9.22M | 0.24% | 90 |
|
|
2016
Q1 | $534M | Sell |
8,225,555
-26,874
| -0.3% | -$1.83M | 0.21% | 107 |
|
|
2015
Q4 | $636M | Sell |
8,252,429
-235,597
| -3% | -$18.7M | 0.25% | 87 |
|
|
2015
Q3 | $699M | Sell |
8,488,026
-134,058
| -2% | -$11.9M | 0.29% | 63 |
|
|
2015
Q2 | $760M | Buy |
8,622,084
+133,263
| +2% | +$12.2M | 0.29% | 62 |
|
|
2015
Q1 | $750M | Buy |
8,488,821
+27,264
| +0.3% | +$2.42M | 0.29% | 66 |
|
|
2014
Q4 | $703M | Buy |
8,461,557
+216,177
| +3% | +$17.9M | 0.28% | 72 |
|
|
2014
Q3 | $695M | Buy |
8,245,380
+363,505
| +5% | +$29.4M | 0.29% | 64 |
|
|
2014
Q2 | $639M | Buy |
7,881,875
+132,836
| +2% | +$10.4M | 0.26% | 73 |
|
|
2014
Q1 | $590M | Sell |
7,749,039
-187,675
| -2% | -$13.7M | 0.25% | 88 |
|
|
2013
Q4 | $572M | Sell |
7,936,714
-195,762
| -2% | -$13.6M | 0.25% | 87 |
|
|
2013
Q3 | $559M | Sell |
8,132,476
-18,990
| -0.2% | -$1.26M | 0.27% | 80 |
|
|
2013
Q2 | $516M | Buy |
+8,151,466
| New | +$530M | 0.27% | 83 |
|
Other funds holding NVS
Wells Fargo's NVS Position: Q1 2026 in Review
Wells Fargo increased its Novartis (NVS) stake by 2.9% in Q1 2026, buying an estimated $8.22M and bringing the position to 1,895,677 shares worth $290M. The position accounts for 0.05% of the portfolio, ranked #287.
Wells Fargo first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $760M in Q2 2015. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Wells Fargo held 1,895,677 shares of Novartis worth $290M as of Q1 2026.
- Wells Fargo bought 53,634 Novartis shares in Q1 2026, an estimated $8.22M.
- Novartis made up 0.05% of Wells Fargo's portfolio in Q1 2026, its #287 holding.
- Wells Fargo first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Novartis position peaked at $760M in Q2 2015.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.